You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 21, June 2, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  State of the Art/Review
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Drug and Neurotransmitter Receptors

New Perspectives With Clinical Relevance

Solomon H. Snyder, MD

JAMA. 1989;261(21):3126-3129.


Abstract

Our understanding of drug and neurotransmitter receptors has been greatly advanced by receptor binding techniques. The theme of multiple-receptor subtypes with clinical relevance is highlighted by calcium antagonist and benzodiazepine receptors. Numerous drugs may exert therapeutic and untoward effects via calcium channels. Examples include effects of loperamide hydrochloride on diarrhea, the phenothiazine thioridazine hydrochloride on cardiac and ejaculatory function, and the neuromuscular toxicity of aminoglycosides. Elevated numbers of calcium antagonist receptors in hypertrophic cardiomyopathy may be involved in the pathophysiology of this disease. Benzodiazepines act via discrete central and peripheral receptors. At central receptors, benzodiazepines facilitate the inhibitory effects of the neurotransmitter -y-aminobutyric acid. Peripheral benzodiazepine receptors are localized to mitochondria and enriched in several endocrine glands where they are influenced by therapeutic blood levels of benzodiazepines such as diazepam.

(JAMA. 1989;261:3126-3129)



Author Affiliations

From the Departments of Neuroscience, Pharmacology, and Molecular Sciences and Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Md.


Footnotes

Reprint requests to Department of Neuroscience, The Johns Hopkins School of Medicine, 725 N Wolfe St, Baltimore, MD 21205 (Dr Snyder).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacodynamic Issues Relevant to Geriatric Psychopharmacology
Pollock et al.
J Geriatr Psychiatry Neurol 1990;3:221-228.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.